Correction: NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker.


Journal

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 18 5 2020
medline: 18 5 2020
entrez: 17 5 2020
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

pubmed: 32415264
doi: 10.1038/s41379-020-0570-8
pii: S0893-3952(22)00478-1
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

2087

Commentaires et corrections

Type : ErratumFor

Auteurs

Raul Perret (R)

Department of Biopathology, Bergonie Institute, Bordeaux, France. r.perret@bordeaux.unicancer.fr.

Julien Escuriol (J)

Department of Biopathology, Bergonie Institute, Bordeaux, France.
Bordeaux University, Talence, France.

Valérie Velasco (V)

Department of Biopathology, Bergonie Institute, Bordeaux, France.

Laetitia Mayeur (L)

Department of Biopathology, Bergonie Institute, Bordeaux, France.

Isabelle Soubeyran (I)

Department of Biopathology, Bergonie Institute, Bordeaux, France.
INSERM U1218, ACTION Unit, Bordeaux, France.

Christophe Delfour (C)

Department of Pathology, Montpellier University Hospital, Montpellier, France.

Sébastien Aubert (S)

Department of Pathology, Institut de Pathologie, Univ. Lille, CHU Lille, F-59000, Lille, France.

Marc Polivka (M)

Department of Pathology, APHP, Hôpital Cochin, DMU Imagina, Université de Paris, F-75014, Paris, France.

Marie Karanian (M)

Department of Pathology, Leon Berard Center, Lyon, France.
Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.

Alexandra Meurgey (A)

Department of Pathology, Leon Berard Center, Lyon, France.

Sophie Le Guellec (S)

Department of Pathology, Claudius Regaud Institute, Toulouse-Oncopole, Toulouse, France.

Noelle Weingertner (N)

Department of Pathology, Strasbourg Regional University Hospital (Hautepierre Hospital), Strasbourg, France.

Sylvia Hoeller (S)

Department of Pathology, Hospital of the University of Basel, Basel, Switzerland.

Jean-Michel Coindre (JM)

Department of Biopathology, Bergonie Institute, Bordeaux, France.
Bordeaux University, Talence, France.

Frédérique Larousserie (F)

Department of Pathology, APHP-Cochin Hospital, Paris, France.

Gaëlle Pierron (G)

Department of Tumor Biology, Curie Institute, Paris, France.

Franck Tirode (F)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.

François Le Loarer (F)

Department of Biopathology, Bergonie Institute, Bordeaux, France. f.le-loarer@bordeaux.unicancer.fr.
Bordeaux University, Talence, France. f.le-loarer@bordeaux.unicancer.fr.
INSERM U1218, ACTION Unit, Bordeaux, France. f.le-loarer@bordeaux.unicancer.fr.

Classifications MeSH